MFBTD
NKTR icon

MB Financial Bank - Trust Department’s Nektar Therapeutics NKTR Stock Holding History

MB Financial Bank - Trust Department’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-27
Closed -$7K – 411
2015
Q4 		$7K Hold
27
– – ﹤0.01% 334
2015
Q3 		$4K Hold
27
– – ﹤0.01% 469
2015
Q2 		$5K Hold
27
– – ﹤0.01% 429
2015
Q1 		$4K Buy
+27
New +$5.55K ﹤0.01% 392

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MB Financial Bank - Trust Department's NKTR Position: Q1 2016 in Review

MB Financial Bank - Trust Department sold out of Nektar Therapeutics (NKTR) in Q1 2016, closing a stake of 27 shares — an estimated $7K sold.

MB Financial Bank - Trust Department first reported a position in NKTR in Q1 2015 and held it in 4 quarters. The position peaked at $7K in Q4 2015. 176 funds tracked by Wall St. Rank hold NKTR as of Q1 2016.

  • MB Financial Bank - Trust Department reported no remaining Nektar Therapeutics position as of Q1 2016 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 27 Nektar Therapeutics shares in Q1 2016, an estimated $7K.
  • MB Financial Bank - Trust Department first reported a position in Nektar Therapeutics in Q1 2015 and held it in 4 quarters.
  • MB Financial Bank - Trust Department's Nektar Therapeutics position peaked at $7K in Q4 2015.
  • 176 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2016.

Based on MB Financial Bank - Trust Department's 13F filing for Q1 2016, filed 15 Apr 2016.